RhumbLine Advisers’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-79,615
Closed -$162K 3093
2016
Q1
$162K Hold
79,615
﹤0.01% 2801
2015
Q4
$197K Buy
79,615
+7,525
+10% +$22.3K ﹤0.01% 2805
2015
Q3
$187K Buy
72,090
+2,523
+4% +$6.57K ﹤0.01% 2811
2015
Q2
$218K Sell
69,567
-5,395
-7% -$18.5K ﹤0.01% 2846
2015
Q1
$214K Buy
74,962
+14,300
+24% +$36.6K ﹤0.01% 2803
2014
Q4
$157K Buy
60,662
+1,850
+3% +$8.1K ﹤0.01% 2874
2014
Q3
$439K Hold
58,812
﹤0.01% 2291
2014
Q2
$693K Buy
58,812
+19,742
+51% +$210K ﹤0.01% 2071
2014
Q1
$454K Sell
39,070
-2,330
-6% -$27.4K ﹤0.01% 2287
2013
Q4
$451K Sell
41,400
-400
-1% -$3.94K ﹤0.01% 2317
2013
Q3
$450K Sell
41,800
-47
-0.1% -$535 ﹤0.01% 2279
2013
Q2
$490K Buy
+41,847
New +$418K ﹤0.01% 2273

RhumbLine Advisers's SZYM Position: Q2 2016 in Review

RhumbLine Advisers sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 79,615 shares — an estimated $162K sold.

RhumbLine Advisers first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $693K in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • RhumbLine Advisers reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • RhumbLine Advisers sold 79,615 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $162K.
  • RhumbLine Advisers first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • RhumbLine Advisers's SOLAZYME INC COM STK (DE) position peaked at $693K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.